1. Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer
   Stefan Mereiter et al, 2016, Front. Oncol. CrossRef
2. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer
   Liang Wang et al, 2016 CrossRef
3. RNA interference-mediated silencing of ppGalNAc-T1 and ppGalNAc-T2 inhibits invasion and increases chemosensitivity potentially by reducing terminal α2,3 sialylation and MMP14 expression in triple-negative breast cancer cells
   Hao Qiu et al, 2017 CrossRef
4. Establishment of a highly metastatic model with a newly isolated lung adenocarcinoma cell line
   YONG-QI CUI et al, 2015 CrossRef
5. Mucin-Type O-Glycosylation in Gastric Carcinogenesis
   Henrique Duarte et al, 2016, Biomolecules CrossRef
6. Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3
   Tomoyoshi Komiyama et al, 2016, IJMS CrossRef
7. MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11
   Yao Wang et al, 2018, Prostate CrossRef
8. Barbaloin loaded polydopamine-polylactide-TPGS (PLA-TPGS) nanoparticles against gastric cancer as a targeted drug delivery system: Studies in vitro and in vivo
   Yi-Ran Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
9. Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer
   Showkat Ahmad Bhat et al, 2018, Hematology/Oncology and Stem Cell Therapy CrossRef
10. The polypeptide N -acetylgalactosaminyltransferase 4 exhibits stage-dependent expression in colorectal cancer and affects tumorigenesis, invasion and differentiation
    Xialin Yan et al, 2018, FEBS J CrossRef
11. null
    Celso A. Reis et al, 2016 CrossRef
12. Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway
    Liwei Guo et al, 2016, Atherosclerosis CrossRef
13. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives
    Joanne Chia et al, 2016, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
14. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen
    C. Fu et al, 2016, HLA CrossRef
15. Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37
    Olga Sokolova et al, 2018, Oncotarget CrossRef
16. Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
    Shin-Yun Liu et al, 2016, Oncotarget CrossRef
17. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
    Miao-Juei Huang et al, 2015, Oncotarget CrossRef
18. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation
    Zhi-Qiang Wang et al, 2014, Oncotarget CrossRef
19. Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells.
    Iwona Radziejewska, 0 CrossRef
20. C1GALT1 in health and disease (Review)
    Xiaojie Sun et al, 2021, Oncol Lett CrossRef
21. Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells.
    Iwona Radziejewska, 0 CrossRef
22. Small molecule inhibitors of mammalian glycosylation
    Karim Almahayni et al, 2022, Matrix Biology Plus CrossRef
23. Mutual regulation between glycosylation and transforming growth factor-β isoforms signaling pathway
    Zhuo Chen et al, 2023, International Journal of Biological Macromolecules CrossRef
24. Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
    Huimei Xu et al, 2023, BMC Med Genomics CrossRef
25. null
    Wagner B. Dias et al, 2024 CrossRef